Overview
Salaries
Products
People
Growth
Offices
Financials

Funding and backers

Backers
2
Y Combinator, Portfolia
Momentum
0/100
no fresh signals
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Jun 2018 Went through Y Combinator
Tractionpublic signals, read monthly
Web presence
top 7%
of 133.2M domains by links, Common Crawl
Backed byfrom the funds' portfolios and accelerator catalogs
Similar startupsby what they do, their industry and backers
TwoStep11-50 employees
TwoStep Therapeutics. Developing tumor-targeted therapies with broad applicability across solid tumors.
ValarlabsVenture round $4.1M · 4 yr ago • Founded 2021 • 11-50 employees
Valar Labs makes diagnostics that use AI to interpret solid tumors and deliver insights, so physicians and patients can make informed…
Waypoint Bio11-50 employees
Waypoint Bio is a biotechnology company pioneering the next generation of cell therapies for solid tumors.
Current Surgical11-50 employees • 6 roles
Surgery Reinvented - Current Surgical targets early-stage solid tumors in areas where traditional surgical techniques fail.
OutpacebioVenture round $56M · 2 yr ago • Founded 2020 • 51-200 employees
Revolutionizing solid tumor treatment through AI-powered protein engineering. OUTSMART™, OUTLAST™, and OUTSPACER™ technologies enhance…
Dispatch BioFounded 2022 • 51-200 employees • 7 roles
Learn how Dispatch Biotherapeutics is expanding the curative potential of immunotherapies by dispatching its Flare platform to overcome…

Overview

RNA Diagnostics. Outside of our pandemic work, we use genomics and machine learning to detect residual solid tumor.